Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02212210 · ClinicalTrials.gov registry record · Early Phase 1

Maternal Epidural Steroids and Hyperthemia

A Early Phase 1 study, sponsored by Medical University of South Carolina.

Terminated
Registry status
Early Phase 1
Development phase
135
Enrollment target

NCT02212210 is a Early Phase 1 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 135 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02212210, a Early Phase 1 study, was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
Early Phase 1
Development phase
135 participants
Enrollment target

Study Summary

The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.

Interventions

  • DRUG Normal saline
  • DRUG Methylprednisolone

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2012-02
Est. Completion 2015-10
Phase Early Phase 1

What the Registry Record Tells You About NCT02212210

The ClinicalTrials.gov registry entry for NCT02212210 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.

NCT02212210 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02212210 about?

NCT02212210 is a clinical study titled "Maternal Epidural Steroids and Hyperthemia". The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.

What is the current status of trial NCT02212210?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 135 participants. The study started on 2012-02. Estimated completion is 2015-10.

What interventions are being tested in trial NCT02212210?

The interventions under investigation include: Normal saline (DRUG), Methylprednisolone (DRUG).

Who is sponsoring clinical trial NCT02212210?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.